BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38865405)

  • 1. Prevalence of HBsAg among Moroccan HIV-1 infected patients and APOBEC3G variant frequencies in HIV-1/HBV co-infection.
    Belbacha I; Bensghir R; Filali Marhoum K; Laboudi M; Hajoutt K; Elharti E; Sadki K; Oumzil H
    J Infect Dev Ctries; 2024 May; 18(5):779-786. PubMed ID: 38865405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.
    Compaore TR; Diarra B; Assih M; Obiri-Yeboah D; Soubeiga ST; Ouattara AK; Tchelougou D; Bisseye C; Bakouan DR; Compaore IP; Dembele A; Djigma WF; Simpore J
    BMC Infect Dis; 2016 Jul; 16():336. PubMed ID: 27449138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.
    Compaore TR; Soubeiga ST; Ouattara AK; Obiri-Yeboah D; Tchelougou D; Maiga M; Assih M; Bisseye C; Bakouan D; Compaore IP; Dembele A; Martinson J; Simpore J
    PLoS One; 2016; 11(1):e0146386. PubMed ID: 26741797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
    J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.
    Hønge BL; Jespersen S; Medina C; Té Dda S; da Silva ZJ; Lewin S; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Krarup H;
    PLoS One; 2014; 9(6):e99971. PubMed ID: 24915064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.
    Freitas SZ; Soares CC; Tanaka TS; Lindenberg AS; Teles SA; Torres MS; Mello FC; Mendes-Corrêa MC; Savassi-Ribas F; Motta-Castro AR
    Braz J Infect Dis; 2014; 18(5):473-80. PubMed ID: 24662138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China.
    Huang SM; Cai WP; Hu FY; Lan Y; Liao BL; Chen YP; Tang XP
    Int J STD AIDS; 2016 Sep; 27(10):890-7. PubMed ID: 26384940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.
    Wandeler G; Mulenga L; Vinikoor MJ; Kovari H; Battegay M; Calmy A; Cavassini M; Bernasconi E; Schmid P; Bolton-Moore C; Sinkala E; Chi BH; Egger M; Rauch A;
    Int J Infect Dis; 2016 Oct; 51():97-102. PubMed ID: 27596685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia.
    Wasihun Y; Asnake D; Kebede N
    BMC Infect Dis; 2024 May; 24(1):460. PubMed ID: 38693473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
    Baseke J; Musenero M; Mayanja-Kizza H
    Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
    Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
    J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult HCV and occult HBV coinfection in Iranian human immunodeficiency virus-infected individuals.
    Jamshidi S; Bokharaei-Salim F; Esghaei M; Bastani MN; Garshasbi S; Chavoshpour S; Dehghani-Dehej F; Fakhim S; Khanaliha K
    J Med Virol; 2020 Dec; 92(12):3354-3364. PubMed ID: 32232978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
    Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
    Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.
    Toyé RM; Lô G; Diop-Ndiaye H; Cissé AM; Ndiaye AJS; Kébé-Fall K; Dramé A; Cohen D; Pujol FH; Mboup S; Boye CS; Chemin I; Laborde-Balen G; Taverne B; Touré-Kane C
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101502. PubMed ID: 32828748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort.
    Ladep NG; Agaba PA; Agbaji O; Muazu A; Ugoagwu P; Imade G; Cooke G; McCormack S; Taylor-Robinson SD; Idoko J; Kanki P
    World J Gastroenterol; 2013 Mar; 19(10):1602-10. PubMed ID: 23538773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of Hepatitis B Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database.
    Aurpibul L; Kariminia A; Vibol U; Fong MS; Le ON; Hansudewechakul R; Bunupuradah T; Kurniati N; Chokephaibulkit K; Kumarasamy N; Wati DK; Yusoff NKN; Razali KAM; Nallusamy RA; Sohn AH; Lumbiganon P;
    Pediatr Infect Dis J; 2018 Aug; 37(8):788-793. PubMed ID: 29846357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and/or C co-infection in HIV infected patients: a study in a tertiary care centre from South India.
    Chandra N; Joshi N; Raju YS; Kumar A; Teja VD
    Indian J Med Res; 2013 Dec; 138(6):950-4. PubMed ID: 24521641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.